A new type of MAML2 fusion in mucoepidermoid carcinoma

Genes Chromosomes and Cancer

Volumn 47, Issue 3, 2008, Pages 203-206

  Fehr, André ^a   Röser, Kerstin ^b   Heidorn, Klaus ^c   Hallas, Cora ^c   Löning, Thomas ^d   Bullerdiek, Jörn ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Institute of Haematopathology   (Germany)

^d ALBERTINEN KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREB REGULATED TRANSCRIPTIONAL COACTIVATOR; FORMALDEHYDE; ONCOPROTEIN; PARAFFIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CHIMERA; CONTROLLED STUDY; CRTC3 GENE; FUSION GENE; GENE; GENE EXPRESSION; GENE FUSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAML2 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, MUCOEPIDERMOID; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 38549121686     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20522     Document Type: Article

References (19)

1. Behboudi A, Enlund V, Winnes M, Andren Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Makitie A, Grenman R, Mark J, Stenman G. 2006. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45:470-481.
2. Bullerdiek J, Haubrich J, Meyer K, Bartnizke S. 1988. Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet 35:129-132.
3. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M. 2003. TORCs: Transducers of regulated CREB activity. Molec Cell 12:413-423.
4. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ. 2005. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65:7137-7144.
5. Enlund F, Behboudi A, Andrén Y, Öberg C, Lendahl U, Mark J, Stenman G. 2004. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 292:21-28.
6. Goode RK, El Naggar AK. 2005. Mucoepidermoid carcinoma. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumors. Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press, pp. 219-220.
7. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, Orth AP, Miraglia L, Meltzer J, Garza D, Chirn GW, McWhinnie E, Cohen D, Skelton J, Terry R, Yu Y, Bodian D, Buxton FP, Zhu J, Song C, Labow MA. 2003. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Nat Acad Sci USA 100:12147-12152.
8. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A, Witters LA, Nakamura H, Okamoto M. 2006. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 273:2730-2748.
9. Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ. 2006. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25:6128-6132.
10. Lin SE, Oyama T, Nagase T, Harigaya K, Kitagawa M. 2002. Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 277:50612-50620.
11. Luna MA. 2006. Salivary mucoepidermoid carcinoma: revisited. Adv Anat Pathol 13:293-307.
12. Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I. 2004. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn 6:205-210.
13. Mitelman Database of Chromosome Aberrations in Cancer. June 2007. Mitelman F, Johansson B, Mertens F, editors. Available at: http://cgap.nci.nih. gov/Chromosomes/Mitelman.
14. Nemoto N, Suzukawa K, Shimizu S, Shinagawa A, Takei N, Taki T, Hayashi Y, Kojima H, Kawakami Y, Nagasawa T. 2007. Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23). Genes Chromosomes Cancer 46:813-819.
15. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Fumoto T, Nakamura S, Nagai N, Hasegawa Y, Inagaki H. 2006. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res 12:3902-3907.
16. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. 2003. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33:208-213.
17. Wu L, Aster JC, Blaeklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. 2000. MAML1, a human homologue of Drosophila master-mind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26:484-489.
18. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. 2002. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 22:7688-7700.
19. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, Griffin JD. 2005. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24:2391-2402.